![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CV TECHNOLOGIES-MAKERS OF COLD-FX-POSTS $10.1 MILLION NET AFTER TAX EARNINGS ON RECORD REVENUE
CV TECHNOLOGIES-MAKERS OF COLD-FX-POSTS $10.1 MILLION NET AFTER TAX EARNINGS ON RECORD REVENUE
November 30, 2005
CV Technologies Inc. (CVT) (TSX VENTURE:CVQ) today released its financial statement for fiscal 2005 showing record sales and profits. The Company -- maker of COLD-fX -- ended the year with net sales of $31.9 million -- an increase of 398% over the $6.4 million achieved the previous year. More striking was the Company's $10.1 million in net after tax profit which is 67 times greater than the $151 thousand that the Company recorded in fiscal 2004 -- the Company's first profitable year.
CCNMatthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=569920)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct